Ulta Beauty, Inc. (ULTA) Stock Forecast
Data as of May 2, 2026Consumer Cyclical · Current price $533.11 (-0.86%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 13, 2026 | Michael Lasser | UBS | $810.00 | +51.9% |
| Mar 9, 2026 | Dana Telsey | Telsey Advisory | $715.00 | +34.1% |
| Mar 9, 2026 | Adrienne Yih | Barclays | $712.00 | +33.6% |
| Jan 21, 2026 | Strong Buy | Raymond James | $790.00 | +48.2% |
| Jan 7, 2026 | Michael Lasser | UBS | $780.00 | +46.3% |
| Dec 17, 2025 | Mark Altschwager | Robert W. Baird | $700.00 | +31.3% |
| Dec 10, 2025 | Rupesh Parikh | Oppenheimer | $675.00 | +26.6% |
| Dec 5, 2025 | Dana Telsey | Telsey Advisory | $640.00 | +20.0% |
| Dec 5, 2025 | Mark Altschwager | Robert W. Baird | $670.00 | +25.7% |
| Dec 2, 2025 | Anna Andreeva | Piper Sandler | $590.00 | +10.7% |
| Oct 10, 2025 | Susan Anderson | Canaccord Genuity | $653.00 | +22.5% |
| Sep 25, 2025 | Kristina Ruggeri | Argus Research | $570.00 | +6.9% |
| Aug 29, 2025 | Michael Lasser | UBS | $680.00 | +27.6% |
| Aug 29, 2025 | Susan Anderson | Canaccord Genuity | $650.00 | +21.9% |
| Aug 25, 2025 | Dana Telsey | Telsey Advisory | $590.00 | +10.7% |
| Aug 12, 2025 | Rupesh Parikh | Oppenheimer | $600.00 | +12.5% |
| Jan 7, 2025 | Korinne Wolfmeyer | Piper Sandler | $425.00 | -20.3% |
| Jan 7, 2025 | Susan Anderson | Canaccord Genuity | $538.00 | +0.9% |
| Dec 9, 2024 | Anthony Chukumba | Loop Capital Markets | $480.00 | -10.0% |
| Dec 5, 2024 | Mark Altschwager | Robert W. Baird | $440.00 | -17.5% |
Top Analysts Covering ULTA
ULTA vs Sector & Market
| Metric | ULTA | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.14 | 2.53 | 2.41 |
| Analyst Count | 37 | 13 | 18 |
| Target Upside | +36.4% | +417.4% | +14.9% |
| P/E Ratio | 21.57 | 11.24 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $2.90B | $3.01B | $3.07B | 16 |
| 2026-10-31 | $2.94B | $3.01B | $3.06B | 8 |
| 2027-01-31 | $4.02B | $4.11B | $4.19B | 8 |
| 2027-04-30 | $3.18B | $3.26B | $3.32B | 14 |
| 2027-07-31 | $3.08B | $3.15B | $3.21B | 11 |
| 2027-10-31 | $3.08B | $3.15B | $3.21B | 8 |
| 2028-01-31 | $4.19B | $4.29B | $4.37B | 7 |
| 2029-01-31 | $14.68B | $14.68B | $14.69B | 11 |
| 2030-01-31 | $14.86B | $15.09B | $15.28B | 5 |
| 2031-01-31 | $16.02B | $16.27B | $16.48B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $5.54 | $6.22 | $6.57 | 14 |
| 2026-10-31 | $5.90 | $6.08 | $6.23 | 6 |
| 2027-01-31 | $9.18 | $9.46 | $9.69 | 6 |
| 2027-04-30 | $7.32 | $7.54 | $7.73 | 11 |
| 2027-07-31 | $6.74 | $6.95 | $7.12 | 6 |
| 2027-10-31 | $6.40 | $6.60 | $6.76 | 10 |
| 2028-01-31 | $9.93 | $10.23 | $10.48 | 11 |
| 2029-01-31 | $32.15 | $34.78 | $36.62 | 9 |
| 2030-01-31 | $36.08 | $36.83 | $37.44 | 3 |
| 2031-01-31 | $42.14 | $43.01 | $43.72 | 4 |
Frequently Asked Questions
What is the analyst consensus for ULTA?
The consensus among 37 analysts covering Ulta Beauty, Inc. (ULTA) is Buy with an average price target of $715.07.
What is the highest price target for ULTA?
The highest price target for ULTA is $810.00, set by Michael Lasser at UBS on 2026-03-13.
What is the lowest price target for ULTA?
The lowest price target for ULTA is $240.00, set by Anthony Chukumba at Loop Capital Markets on 2024-04-08.
How many analysts cover ULTA?
37 analysts have issued ratings for Ulta Beauty, Inc. in the past 12 months.
Is ULTA a buy or sell right now?
Based on 37 analyst ratings, ULTA has a consensus rating of Buy (2.14/5) with a +36.4% upside to the consensus target of $715.07.
What are the earnings estimates for ULTA?
Analysts estimate ULTA will report EPS of $6.22 for the period ending 2026-07-31, with revenue estimated at $3.01B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.